Skip to content

Study of the effect on cognitive function by continuous intake of polyamine

Study of the effect on cognitive function by continuous intake of polyamine - Study of the effect on cognitive function by continuous intake of polyamine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049672
Enrollment
60
Registered
2022-12-02
Start date
2022-12-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Ingest 3 tablets of the test foods (capsules containing polyamine) each after breakfast, lunch and dinner (total 9 tablets) daily for 12 weeks. Ingest 3 tablets of the test foods (placebo) each after

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2. Healthy Japanese who are 40 years old or more when obtaining consent 3. Persons who are aware of forgetfulness 4. Persons whose MMSE score is 24 or higher at screening

Exclusion criteria

Exclusion criteria: 1. Persons who have chronic illness, receiving medication, have a serious disease history 2. Patients suffering from cancer, familial colorectal adenomatosis, or H. pylori infection. 3. Persons who have any allergies to the ingredients used in the test food (especially persons who have allergies to wheat) 4. Persons who regularly take of polyamine-containing supplements 5. Persons who consume at least one pack of natto every day. 6. Persons who consume at least one pack of soy milk (approximately200ml) every day. 7. Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect cognitive function. 8. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 9. Persons who were judged as inappropriate for study participants by the principal investigator 10. Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Design outcomes

Primary

MeasureTime frame
Cognitive function tests (Cognitrax)

Secondary

MeasureTime frame
Mini Mental State Examination Questionnaire regarding cognitive function (VAS) Blood pressure (Systolic, Diastolic and plus) Questionnaire regarding stress (VAS) Japanese Perceived Stress Scale Brief Job Stress Questionnaire Urine polyamine Blood polyamine

Countries

Japan

Contacts

Public ContactKosei Nishikawa

Healthcare Systems Co., Ltd. Clinical Research Department

nishikawa@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026